{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:56:20Z","timestamp":1791053780429,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2192,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/jid.2009.175","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T08:43:27Z","timestamp":1248338607000},"page":"2875-2885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["FOXP3+CD25\u2212 Tumor Cells with Regulatory Function in S\u00e9zary Syndrome"],"prefix":"10.1016","volume":"129","author":[{"given":"Julia B.","family":"Heid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Oberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergij","family":"Goerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Suri-Payer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Detlev","family":"Klemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2009.175_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0609.2008.01105.x","article-title":"Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells","volume":"81","author":"Abe","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1038\/jid.2009.175_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2009.175_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-0609.2007.00990.x","article-title":"Is FOXP3 expressed in cutaneous T-cell lymphomas?","volume":"80","author":"Banham","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1038\/jid.2009.175_bb0025","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1038\/jid.2009.175_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2009.175_bb0035","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2009.175_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2009.175_bb0045","first-page":"725","article-title":"Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1038\/jid.2009.175_bb0050","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","article-title":"Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma","volume":"49","author":"Capriotti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/jid.2009.175_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxh366","article-title":"Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells","volume":"18","author":"Chen","year":"2006","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2009.175_bb0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF02505293","article-title":"Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3\/1+3, MS-1+\/-, 25F9-) in psoriatic dermis","volume":"288","author":"Djemadji-Oudjiel","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/jid.2009.175_bb0065","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","article-title":"The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells","volume":"68","author":"Ebert","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2009.175_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2009.175_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.175.1.32","article-title":"In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death","volume":"175","author":"Fritzsching","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.175_bb0080","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2009.175_bb0085","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.175_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0609.2008.01064.x","article-title":"FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations","volume":"80","author":"Gjerdrum","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1038\/jid.2009.175_bb0095","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/ijc.23284","article-title":"Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model","volume":"122","author":"Grauer","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2009.175_bb0100","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pone.0001612","article-title":"FOXP3 promoter demethylation reveals the committed Treg population in humans","volume":"3","author":"Janson","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1038\/jid.2009.175_bb0105","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1158\/1078-0432.CCR-0721-03","article-title":"Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy","volume":"10","author":"Jones","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2009.175_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/jid.2009.175_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1038\/jid.2009.175_bb0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2133.2008.08739.x","article-title":"The diagnosis of Sezary syndrome on peripheral blood by flow cytometry requires the use of multiple markers","volume":"159","author":"Klemke","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.175_bb0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2404182","article-title":"Paucity of FOXP3(+) cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas","volume":"20","author":"Klemke","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.175_bb0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2005.06676.x","article-title":"Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome","volume":"153","author":"Klemke","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.175_bb0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1349-7006.2005.00080.x","article-title":"Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells","volume":"96","author":"Kohno","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1038\/jid.2009.175_bb0140","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.4049\/jimmunol.181.4.2506","article-title":"Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes","volume":"181","author":"Kasprzycka","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.175_bb0145","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/leu.2008.224","article-title":"Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome","volume":"22","author":"Krejsgaard","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.175_bb0150","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.4049\/jimmunol.174.10.5968","article-title":"Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells","volume":"174","author":"Maeda","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.175_bb0155","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.175.5.3053","article-title":"Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice","volume":"175","author":"Masteller","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.175_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.leu.2403628","article-title":"Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells","volume":"19","author":"Matsubara","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.175_bb0165","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1182\/blood-2007-08-105395","article-title":"Local and systemic induction of CD4+CD25+ regulatory T cell population by non-Hodgkin's lymphoma","volume":"111","author":"Mittal","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jid.2009.175_bb0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/25E9Y7RRAY84HTAT","article-title":"A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome","volume":"125","author":"Morice","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2009.175_bb0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1309\/3A32DTVMH640M2QA","article-title":"Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques","volume":"121","author":"Morice","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2009.175_bb0180","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.179.6.3578","article-title":"Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling","volume":"179","author":"Oberle","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/jid.2009.175_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2006.10.014","article-title":"Transient regulatory T-cells: a state attained by all activated human T-cells","volume":"123","author":"Pillai","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1038\/jid.2009.175_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000073090","article-title":"Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition","volume":"207","author":"Poenitz","year":"2003","journal-title":"Dermatology"},{"key":"10.1038\/jid.2009.175_bb0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1038\/jid.2009.175_bb0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1126\/science.1142331","article-title":"Emerging challenges in regulatory T cell function and biology","volume":"317","author":"Sakaguchi","year":"2007","journal-title":"Science"},{"key":"10.1038\/jid.2009.175_bb0205","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1038\/jid.2009.175_bb0210","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/eji.200737593","article-title":"Regulatory T cells\u2014a brief history and perspective","volume":"37","author":"Sakaguchi","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1038\/jid.2009.175_bb0215","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2009.175_bb0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","article-title":"Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells","volume":"99","author":"Shimauchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1038\/jid.2009.175_bb0225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","article-title":"CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma","volume":"126","author":"Talpur","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.175_bb0230","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","article-title":"Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma","volume":"126","author":"Tiemessen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.175_bb0235","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","article-title":"Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype","volume":"110","author":"Tran","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2009.175_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2009.175_bb0245","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI111379","volume":"73","author":"Waldmann","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2009.175_bb0250","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","article-title":"Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+","volume":"112","author":"Walker","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2009.175_bb0255","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.jid.5700121","article-title":"A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection","volume":"126","author":"Walsh","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.175_bb0260","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1073\/pnas.0501701102","article-title":"Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter","volume":"102","author":"Wan","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1038\/jid.2009.175_bb0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/jid.2009.175_bb0270","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2009.175_bb0275","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"10.1038\/jid.2009.175_bb0280","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4049\/jimmunol.181.3.1683","article-title":"Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3","volume":"181","author":"Zheng","year":"2008","journal-title":"J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15341737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15341737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:33:10Z","timestamp":1743939190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15341737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022202X15341737"],"URL":"https:\/\/doi.org\/10.1038\/jid.2009.175","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXP3+CD25\u2212 Tumor Cells with Regulatory Function in S\u00e9zary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2009.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}